New Cancer Cell Study Backs CEL-SCI’s Early Approval Bid for Multikine in Head & Neck Cancer
New Cancer Cell Study Backs CEL-SCI’s Early Approval Bid for Multikine in Head & Neck Cancer CEL-SCI Corporation (NYSE American: CVM), a clinical-stage immunotherapy company developing innovative treatments for cancer…
Agitated Solutions Gets FDA IND Nod for Phase 3 Contrast Agent Trial
Agitated Solutions Gets FDA IND Nod for Phase 3 Contrast Agent Trial Agitated Solutions, Incorporated (ASI), a medical technology company focused on cardiovascular imaging innovation, announced a pivotal regulatory milestone…
Guardian Pharmacy Services Expands LTC Reach with Naples Pharmacy Acquisition
Guardian Pharmacy Services Expands LTC Reach with Naples Pharmacy Acquisition Guardian Pharmacy Services, Inc. (NYSE: GRDN), one of the largest and most forward-thinking long-term care (LTC) pharmacy providers in the…
Alpenglow Biosciences to Host AACR 2025 Dinner Talk on Spatial Biology in Endometrial Cancer
Alpenglow Biosciences to Host AACR 2025 Dinner Talk on Spatial Biology in Endometrial Cancer Alpenglow Biosciences, a leading innovator in 3D spatial biology and digital pathology, is pleased to announce…
FDA Approves Opdivo Plus Yervoy® for Untreated MSI-H or dMMR Metastatic Colorectal Cancer
FDA Approves Opdivo Plus Yervoy® for Untreated MSI-H or dMMR Metastatic Colorectal Cancer Bristol Myers Squibb today announced a major milestone in cancer immunotherapy with the U.S. Food and Drug…
Ethris and Lonza Partner to Advance Spray-Dried mRNA Vaccines Targeting Respiratory Illnesses
Ethris and Lonza Partner to Advance Spray-Dried mRNA Vaccines Targeting Respiratory Illnesses In a major step toward transforming the landscape of vaccine development and delivery, Ethris, a clinical-stage biotechnology company…
Avenacy Introduces Propofol Injectable Emulsion, USP to the U.S. Market
Avenacy Introduces Propofol Injectable Emulsion, USP to the U.S. Market Avenacy Launches FDA-Approved Propofol Injectable Emulsion, USP in the United States: A Milestone in Critical Care and Anesthesia Access Avenacy,…
Sail Biomedicines Welcomes Dr. Laura Sepp-Lorenzino to Its Board of Directors
Sail Biomedicines Welcomes Dr. Laura Sepp-Lorenzino to Its Board of Directors Sail Biomedicines, Inc., a pioneering biotechnology company at the forefront of programmable RNA-based medicines and a Flagship Pioneering-founded enterprise,…
Corcept Begins Trial of Relacorilant Combo in Resistant Ovarian Cancer
Corcept Begins Trial of Relacorilant Combo in Resistant Ovarian Cancer Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage biopharmaceutical company focused on the discovery and development of innovative therapies that modulate…
Kashiv BioSciences Obtains $150 Million in Debt Financing from GoldenTree Asset Management
Kashiv BioSciences Obtains $150 Million in Debt Financing from GoldenTree Asset Management Kashiv BioSciences, LLC (“Kashiv” or “the Company”), a fully integrated and innovation-driven biopharmaceutical company, announced today the successful…
Verge Genomics Identifies Digital Biomarkers for Early ALS Progression in VRG50635 Trial
Verge Genomics Identifies Digital Biomarkers for Early ALS Progression in VRG50635 Trial Verge Genomics, a trailblazer in AI-powered drug discovery and development, today announced pivotal findings that could reshape the…
Flatiron Health Partners with Massive Bio to Strengthen Patient Identification and Services
Flatiron Health Partners with Massive Bio to Strengthen Patient Identification and Services In a strategic move poised to reshape the landscape of oncology clinical research, Flatiron Health, a leading health…